PreludeDx is a pioneering company in healthcare technology, specializing in innovative solutions for early stage breast cancer management. With the DCIS test, it empowers patients and clinicians with personalized treatment options, enhancing decision-making processes and improving outcomes in the fields of biotechnology and healthcare services.